Summary
Definition
History and exam
Key diagnostic factors
- presença de fatores de risco
- estímulo de movimento para sintomas
- desconforto epigástrico
- náuseas
- cefaleia
- vômitos
Other diagnostic factors
- suor frio
- xerostomia
- tontura
- bocejos e sonolência
- palidez
- instabilidade e falta de coordenação
Risk factors
- idade infantil
- sexo feminino
- ascendência asiática
- história familiar de cinetose
- história de enxaqueca
- vestibulopatia
- distúrbios visuais
- tabagismo
- desorientação espacial e síndrome do desconforto de deslocamento espacial
- fatores hormonais
- visão/odores desagradáveis ou odor de vômito
- estímulos sensoriais de entrada conflitantes (por exemplo, ler no carro, trens pendulares)
- fatores psicológicos
- tarefas concomitantes espacialmente carregadas
- distúrbio neurológico
Diagnostic tests
1st tests to order
- diagnóstico clínico
Treatment algorithm
cinetose antecipada
cinetose não antecipada
suscetibilidade conhecida
Contributors
Authors
Amir Kheradmand, MD
Associate Professor
Department of Neurology, Neuroscience, Otolaryngology-Head and Neck Surgery, and Laboratory for Computational Sensing and Robotics (LCSR)
John Hopkins University School of Medicine
Baltimore
MD
Disclosures
AK is the author of references cited in this topic.
Qadeer Arshad, PhD
Associate Professor
inAmind Laboratory, College of Life Sciences
University of Leicester
Leicester
UK
Disclosures
QA is the author of references cited in this topic.
Acknowledgements
Dr Amir Kheradmand and Dr Qadeer Arshad would like to gratefully acknowledge Dr Kenneth L. Koch and Dr Michael A. Gresty, the previous contributors to this topic.
Disclosures
KLK and MAG are authors of several references cited in this topic.
Peer reviewers
Alan J. Benson, MB, ChB
Visiting Consultant to the Royal Air Force Centre for Aviation Medicine
Royal Air Force Henlow
UK
Disclosures
AJB declares that he has no competing interests.
David Andrew Green, PhD
Lecturer in Human Cardiorespiratory and Aerospace Physiology
Division of Applied Biomedical Research
Department of Physiology
King's College London
London
UK
Disclosures
DAG declares that he has no competing interests.
Michael von Brevern, MD, PhD
Department of Neurology
Park-Klinik Weissensee
Berlin
Germany
Disclosures
MVB declares that he has no competing interests.
Richard Lewis, MD
Associate Professor
Otolaryngology and Neurology
Harvard Medical School
Boston
MA
Disclosures
RL declares that he has no competing interests.
Peer reviewer acknowledgements
BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.
Disclosures
Peer reviewer affiliations and disclosures pertain to the time of the review.
References
Key articles
Cha YH, Golding JF, Keshavarz B, et al. Motion sickness diagnostic criteria: consensus document of the Classification Committee of the Bárány Society. J Vestib Res. 2021;31(5):327-44.Full text Abstract
Centers for Disease Control and Prevention. CDC Yellow Book 2024: health information for international travel. Section 8: Travel by air, land & sea - motion sickness. May 2023 [internet publication].Full text
Spinks AB, Wasiak J. Scopolamine (hyoscine) for preventing and treating motion sickness. Cochrane Database Syst Rev. 2011;(6):CD002851.Full text Abstract
Reference articles
A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.
Differentials
- Enxaqueca
- Intoxicação alimentar
- Distúrbio vestibular agudo
More DifferentialsGuidelines
- CDC Yellow Book: health information for international travel - motion sickness
- Motion sickness diagnostic criteria: consensus document of the Classification Committee of the Bárány Society
More GuidelinesLog in or subscribe to access all of BMJ Best Practice
Use of this content is subject to our disclaimer